Getting ahead of regulatory changes around PFAS in pharmaceutical packaging
Clarivate
MARCH 14, 2024
With the introduction of a new CMC Intelligence entitlement to address post-approval changes, Clarivate now covers a broader range of the lifecycle of pharmaceutical products. Regulatory manager at a fortune 500 company Implications for stakeholders: As regulations evolve, so must the industry.
Let's personalize your content